1. MARKETS
  2. SECTOR : COMMERCIAL SERVICES & SUPPLIES
  3. INDUSTRY : MISCELLANEOUS COMMERCIAL SERVICES
  4. GRI BIO INC

GRI Bio Inc

XNAS: GRI

Download real time

7.16 0.46 (6.87%)

34.91% Fall from 52W High

50,203 XNAS Volume

High volume+gain today

XNAS 20 Mar, 2025 2:09 PM (EDT)

Watchlist

Portfolio

Share
20S
3W
3O
1T
3.8

Market Cap

Low in industry
-0.5

PE TTM

Negative PE TTM
0

PEG TTM

1

Price to Book

Below industry Median
1.2

Beta 1Year

High Volatility


Insider Trading disclosures for GRI Bio Inc

The latest disclosure was made by Leanne M. Kelly in GRI Bio Inc where a trade of 43,319 Stock Option (Right to Buy) done was reported to US exchanges on Jan. 23, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Leanne M. Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 43,319 43,319 - - Stock Option (Right to Buy)
David Szekeres Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 51,937 51,937 - - Stock Option (Right to Buy)
Roelof Rongen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 30,297 30,297 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 30,297 30,297 - - Stock Option (Right to Buy)
David Baker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 30,297 30,297 - - Stock Option (Right to Buy)
Vipin Kumar Chaturvedi Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 43,319 43,319 - - Stock Option (Right to Buy)
W. Marc Hertz Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 129,730 129,730 - - Stock Option (Right to Buy)
David Szekeres Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 34,483 34,483 - - Stock Option (Right to Buy)
Roelof Rongen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 34,483 34,483 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 34,483 34,483 - - Stock Option (Right to Buy)
David Baker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 34,483 34,483 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters